Related Experiment Video
Updated: Dec 9, 2025

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically
Lydia R Maurer1, Casey M Luckhurst1, Arzo Hamidi2
1Department of Surgery, Massachusetts General Hospital, Boston, MA, United States of America.
Insights
A low dose heparinized saline (LDHS) protocol improved arterial line patency in critically ill COVID-19 patients. This method enhanced line duration without increasing bleeding risk, offering a safe and effective solution for thrombosis prevention.
Area of Science:
- Critical care medicine
- Vascular access
- Thrombosis management
Background:
- Critically ill patients with Coronavirus Disease 2019 (COVID-19) exhibit high rates of line thrombosis.
- Maintaining arterial line (a-line) patency is crucial for hemodynamic monitoring in these patients.
Purpose of the Study:
- To evaluate the safety and efficacy of a low dose heparinized saline (LDHS) arterial line patency protocol.
- To determine if LDHS impacts a-line thrombosis rates and bleeding complications in COVID-19 patients.
Main Methods:
- Observational cohort study comparing patients before and after implementation of an LDHS protocol (10 units/h).
- Included adult COVID-19 patients admitted to the ICU.
- Analyzed a-line patency duration and bleeding complications.
Main Results:
- The LDHS protocol group showed a significantly longer median duration of a-line patency (8.5 days) compared to the pre-LDHS group (2.9 days).
- Baseline characteristics, including age and systemic anticoagulation, were similar between groups.
- The incidence of bleeding complications was comparable between the LDHS and pre-LDHS cohorts (10% vs. 13%).
Conclusions:
- A low dose heparinized saline protocol significantly improves arterial line patency duration in COVID-19 patients.
- The LDHS protocol is a safe and effective strategy, as it does not increase bleeding risk.
- This finding supports the use of LDHS for maintaining arterial line patency in critically ill COVID-19 patients.
Purpose:
Critically ill patients with Coronavirus Disease 2019 (COVID-19) have high rates of line thrombosis. Our objective was to examine the safety and efficacy of a low dose heparinized saline (LDHS) arterial line (a-line) patency protocol in this population.
Materials And Methods:
In this observational cohort study, patients ≥18 years with COVID-19 admitted to an ICU at one institution from March 20-May 25, 2020 were divided into two cohorts. Pre-LDHS patients had an episode of a-line thrombosis between March 20-April 19. Post-LDHS patients had an episode of a-line thrombosis between April 20-May 25 and received an LDHS solution (10 units/h) through their a-line pressure bag.
Results:
Forty-one patients (pre-LDHS) and 30 patients (post-LDHS) were identified. Baseline characteristics were similar between groups, including age (61 versus 54 years; p = 0.24), median Sequential Organ Failure Assessment score (6 versus 7; p = 0.67) and systemic anticoagulation (47% versus 32%; p = 0.32). Median duration of a-line patency was significantly longer in post-LDHS versus pre-LDHS patients (8.5 versus 2.9 days; p < 0.001). The incidence of bleeding complications was similar between cohorts (13% vs. 10%; p = 0.71).
Conclusions:
A LDHS protocol was associated with a clinically significant improvement in a-line patency duration in COVID-19 patients, without increased bleeding risk.
More Related Videos
09:57A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Endocarditis IV: Nursing Management
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Acute Coronary Syndrome IV: Interprofessional Care